Tashkent, Uzbekistan (UzDaily.com) — Abdulla Azizov, Director of the Agency for Pharmaceutical Industry Development, presented Remedy LLC with a certificate confirming its inclusion in the innovative scientific and manufacturing pharmaceutical cluster Tashkent Pharma Park.

As part of this new project, Remedy LLC plans to establish production of next-generation medications for the treatment of infectious, cardiovascular, endocrine, neurological, gastroenterological, allergic, and rheumatological diseases within the Tashkent Pharma Park cluster. The enterprise’s annual production capacity is expected to reach 167 million units of pharmaceutical products.

Remedy LLC was founded in 2003. Its manufacturing plant, producing a wide range of medicines, is located in the Almazar district of Tashkent.